DE69001513D1 - Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln. - Google Patents

Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln.

Info

Publication number
DE69001513D1
DE69001513D1 DE9090112251T DE69001513T DE69001513D1 DE 69001513 D1 DE69001513 D1 DE 69001513D1 DE 9090112251 T DE9090112251 T DE 9090112251T DE 69001513 T DE69001513 T DE 69001513T DE 69001513 D1 DE69001513 D1 DE 69001513D1
Authority
DE
Germany
Prior art keywords
soft capsules
composition containing
polyprenyl compound
containing polyprenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090112251T
Other languages
English (en)
Other versions
DE69001513T2 (de
Inventor
Keizo Uesugu
Masanori Kayano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DE69001513D1 publication Critical patent/DE69001513D1/de
Application granted granted Critical
Publication of DE69001513T2 publication Critical patent/DE69001513T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE90112251T 1989-07-10 1990-06-27 Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln. Expired - Fee Related DE69001513T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17732489 1989-07-10

Publications (2)

Publication Number Publication Date
DE69001513D1 true DE69001513D1 (de) 1993-06-09
DE69001513T2 DE69001513T2 (de) 1993-10-28

Family

ID=16028989

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90112251T Expired - Fee Related DE69001513T2 (de) 1989-07-10 1990-06-27 Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln.

Country Status (13)

Country Link
US (1) US5139740A (de)
EP (1) EP0407815B1 (de)
JP (1) JP3048602B2 (de)
KR (1) KR930000048B1 (de)
CN (1) CN1041600C (de)
AT (1) ATE88902T1 (de)
CA (1) CA2020261A1 (de)
DE (1) DE69001513T2 (de)
DK (1) DK0407815T3 (de)
ES (1) ES2055227T3 (de)
FI (1) FI96169C (de)
GR (1) GR3007793T3 (de)
NO (1) NO177484C (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI901046A0 (fi) * 1989-03-17 1990-03-01 Eisai Co Ltd Stabilisering av polyprenylfoereningen.
JPH06510020A (ja) * 1991-03-29 1994-11-10 ユニバーシティ・オブ・フロリダ 混成リン酸エステル誘導体を経た標的への薬剤供給
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
EP0946159A1 (de) * 1996-12-12 1999-10-06 PHARMACIA & UPJOHN COMPANY Dihydropolyprenol enthaltende oel-zusammensetzung
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
KR102162901B1 (ko) * 2011-09-29 2020-10-08 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
AU2021244695A1 (en) 2020-03-26 2022-11-10 Plx Opco Inc. Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746087A1 (de) * 1977-10-13 1979-04-26 Chinoin Gyogyszer Es Vegyeszet Cyclodextrin-einschlusskomplexe mit indomethacin, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
JPS58172366A (ja) * 1982-04-01 1983-10-11 Kaken Pharmaceut Co Ltd インド−ル酢酸ポリプレニルエステル誘導体、その製造法およびそれを有効成分とする解熱鎮痛消炎剤
DE3500103A1 (de) * 1985-01-04 1986-07-10 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische zubereitung mit einem in wasser und verdauungssaeften schwer loeslichen wirkstoff
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems

Also Published As

Publication number Publication date
DK0407815T3 (da) 1993-06-01
ES2055227T3 (es) 1994-08-16
KR930000048B1 (ko) 1993-01-06
EP0407815B1 (de) 1993-05-05
CA2020261A1 (en) 1991-01-11
JPH03128322A (ja) 1991-05-31
NO177484C (no) 1995-09-27
EP0407815A2 (de) 1991-01-16
ATE88902T1 (de) 1993-05-15
NO177484B (no) 1995-06-19
FI96169B (fi) 1996-02-15
GR3007793T3 (de) 1993-08-31
FI903030A0 (fi) 1990-06-15
NO903058L (no) 1991-01-11
US5139740A (en) 1992-08-18
KR910002443A (ko) 1991-02-25
FI96169C (fi) 1996-05-27
JP3048602B2 (ja) 2000-06-05
CN1048656A (zh) 1991-01-23
CN1041600C (zh) 1999-01-13
DE69001513T2 (de) 1993-10-28
EP0407815A3 (en) 1991-02-27
NO903058D0 (no) 1990-07-09

Similar Documents

Publication Publication Date Title
IL90271A0 (en) Antiviral drug
HUT38950A (en) Process for producing 2-substituted-1,3-propylidene-diphosphonate derivatives and pharmaceutical compositions containing them as active agents
SE8600017D0 (sv) New compound
ATE88902T1 (de) Polyprenylverbindung enthaltende zusammensetzung fuer weiche kapseln.
ES2066060T3 (es) Solucion humectada para impresion litografica.
AU1951392A (en) Naphthylamine polycarboxylic acids
CS717682A2 (en) Insekticidni a akaricidni prostredek a zpusob vyroby ucinnych latek
DE3870954D1 (de) Zahnaerztliche haftmittelzusammensetzung.
DE69001734D1 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
GB8815180D0 (en) Compositions
BR9505655A (pt) Processo direto para preparação de alquíl halodifluoroacetatos
DE3877277D1 (de) Injektionszusammensetzung, die modifiziertes tpa enthaelt.
SG48093A1 (en) Process for the preparation of crystalline taca
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
AU566243B2 (en) Optically active imidazolylpropanols
EP0080592B1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
JPS6471891A (en) Thionophosphonate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee